Selecting a Treatment Regimen
Table 2. Therapies Agent (Brand)
Anastrozole (Arimidex® Exemestane (Aromasin® Letrozole (Femara® Tamoxifen (Nolvadex®
) )* * Generic forms available.
)* )
Dose 1 mg
25 mg 2.5 mg 20 mg
Frequency Once daily Once daily Once daily Once daily
Management of Hormone Receptor-Positive Breast Cancer Postmenopausal
Pre/Perimenopausal
5 years of tamoxifen
2-3 years of tamoxifen
5 years of tamoxifen
Studies are evaluating the role of adding ovarian
suppression to tamoxifen for these women.
AI 2-3 years AI 3-5 years
3